Invesco NASDAQ Biotechnology ETF
IBBQ
14 hedge funds and large institutions have $7.73M invested in Invesco NASDAQ Biotechnology ETF in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
25% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 4
17% more funds holding
Funds holding: 12 → 14 (+2)
6.33% less ownership
Funds ownership: 44.91% → 38.58% (-6.3%)
13% less capital invested
Capital invested by funds: $8.92M → $7.73M (-$1.19M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$84.6K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$77.9K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$33.5K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$21.3K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$9.31K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Mirae Asset Global Investments
Seoul,
South Korea
|
-$1.89M |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$485K |
| 3 |
BBP
Banco BTG Pactual
Rio De Janeiro,
Brazil
|
-$21.5K |
| 4 |
CAL
Capital Analysts LLC
Fort Washington,
Pennsylvania
|
-$9K |
| 5 |
Morgan Stanley
New York
|
-$1.3K |
IBBQ Hedge Fund Activity: Q4 2022 in Review
14 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Invesco NASDAQ Biotechnology ETF (IBBQ) for Q4 2022, worth a combined $7.73M — down 13% from $8.92M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new IBBQ positions and 1 closed out — a net gain of 2 holders — while 5 added to existing stakes and 4 trimmed.
The largest buyer was Raymond James Financial Services Advisors, adding an estimated $84.6K. The largest seller was Mirae Asset Global Investments, cutting an estimated $1.89M.
- 14 institutional investors held Invesco NASDAQ Biotechnology ETF (IBBQ) as of Q4 2022, up from 12 in Q3 2022.
- Funds reported $7.73M of Invesco NASDAQ Biotechnology ETF stock for Q4 2022, down 13% quarter-over-quarter.
- 3 funds opened new Invesco NASDAQ Biotechnology ETF positions in Q4 2022 and 1 closed out, a net change of +2 holders.
- The largest Invesco NASDAQ Biotechnology ETF buyer in Q4 2022 was Raymond James Financial Services Advisors, an estimated $84.6K added.
- The largest Invesco NASDAQ Biotechnology ETF seller in Q4 2022 was Mirae Asset Global Investments, an estimated $1.89M sold.
Based on aggregated 13F filings for Q4 2022.